RNAZ - Transcode Therapeutics, Inc.
0.3418
-0.008 -2.458%
Share volume: 1,032,720
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$0.35
-0.01
-0.02%
Summary score
33%
Profitability
0%
Dept financing
44%
Liquidity
50%
Performance
60%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-87.73%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
63.14%
Debt ratio change over timeo
0%
Current Ratio
1.43%
Quick Ratio
0%
Cash Position Ratio
0.81%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-87.73%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
63.14%
Debt ratio change over timeo
0%
Current Ratio
1.43%
Quick Ratio
0%
Cash Position Ratio
0.81%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-58.71%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
58.03%
Debt ratio change over time
0%
Current Ratio
1.58%
Quick Ratio
0%
Cash Position Ratio
0.82%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RNAZ | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 18.86% | 8.19% | 17.34% |
| Return on assets | -87.73% | 4.09% | 3.09% | 8.21% |
| Return on sales | 0% | 27.43% | 25.26% | 41.18% |
| Return on invested capital | 0% | 8.62% | 7.99% | -219.55% |
| Profitability | 0% | 79% | 59% | 73% |
| Total debt ratio | 63.14% | 82.89% | 60.02% | 55.88% |
| Debt ratio change over time | 0% | -9.8% | -36.79% | 0% |
| Dept financing | 44% | 25% | 18% | 17% |
| Current Ratio | 1.43% | 1.12% | 1.16% | 0% |
| Quick Ratio | 0% | 0.86% | 0.92% | 0% |
| Cash Position Ratio | 0.81% | 0.12% | 0.51% | 0% |
| Liquididy | 50% | 50% | 65% | 51% |
| Short-term ratios | RNAZ | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | 0% | 7.71% | 21.69% | 0% |
| Return on assets | -87.73% | 4.46% | 2.98% | 0% |
| Return on sales | 0% | 29.24% | 25.4% | 0% |
| Return on invested capital | 0% | 5.83% | 22.48% | 0% |
| Profitability | 0% | 65% | 88% | 0% |
| Total debt ratio | 63.14% | 80.89% | 59.04% | 0% |
| Debt ratio change over time | 0% | -57.9% | -209.85% | 0% |
| Dept financing | 45% | 25% | 18% | 0% |
| Current Ratio | 1.43% | 1.12% | 1.16% | 0% |
| Quick Ratio | 0% | 0.86% | 0.92% | 0% |
| Cash Position Ratio | 0.81% | 0.12% | 0.51% | 0% |
| Liquididy | 50% | 47% | 61% | 0% |
